THE UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER and Tempus, a health-tech company focused on personalizing cancer care, and have partnered to bring MI-ONCOSEQ to patients and healthcare providers across the country who are seeking the high quality data and analyses necessary to personalize treatment for their patients. The MI-ONCOSEQ panel was developed at the University...
The Biden administration has left NIH in a weakened state, intensifying politicization of science on Capitol Hill and eroding the bipartisan support the government’s premier biomedical research agency has traditionally enjoyed.
